Key Protein May Lead to Faster Acting Anti-Depression Drugs

PR Newswire, March 23, 2009

NEW YORK, March 23 /PRNewswire-USNewswire/ — Research conducted by Nobel laureate Paul Greengard, Medical Director of The Michael Stern Parkinson’s Research Center at The Rockefeller University, Dr. Jennifer L. Warner-Schmidt in New York and colleagues in Sweden, demonstrated in the Journal of Neuroscience that the brain protein called p11 could lead pharmaceutical companies to develop anti-depression drugs that begin working within hours or days rather than the weeks or even months required by current drugs

Read more…